Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Illinois Business Review.
Press releases published on April 30, 2025

Aware Reports First Quarter 2025 Financial Results
BURLINGTON, Mass., April 30, 2025 (GLOBE NEWSWIRE) -- Aware, Inc. (NASDAQ: AWRE), a leading global authentication company, today reported financial results for the first quarter ended March 31, 2025. Management Commentary “In the first quarter of 2025, we …

FormFactor, Inc. Reports 2025 First Quarter Results
LIVERMORE, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- FormFactor, Inc. (Nasdaq: FORM) today announced its financial results for the first quarter of fiscal 2025 ended March 29, 2025. Quarterly revenues were $171.4 million, a decrease of 9.6% compared to $ …

Medallion Bank Reports 2025 First Quarter Results and Declares Series F Preferred Stock Dividend
SALT LAKE CITY, April 30, 2025 (GLOBE NEWSWIRE) -- Medallion Bank (Nasdaq: MBNKP, the “Bank”), an FDIC-insured bank providing consumer loans for the purchase of recreational vehicles, boats, and home improvements, along with loan origination services to …

Sezzle to Hold an Annual Shareholder Meeting, Report 1Q25 Results, and Attend Investor Conferences
Minneapolis, MN, April 30, 2025 (GLOBE NEWSWIRE) -- Sezzle Inc. (NASDAQ: SEZL) (Sezzle or Company) // Purpose-driven digital payment platform, Sezzle, has scheduled its 2025 Annual Meeting of Stockholders for June 10, 2025, at 5:00 pm ET. The meeting will …

Mdxhealth to Release First Quarter 2025 Financial Results on May 14
Company to Host Conference Call with Live Q…

Information relative au nombre total de droits de vote et d’actions composant le capital social au 11 avril 2025
Article R. 22-10-23 du Code de commerce Place de cotation : Euronext Paris Code ISIN / Mnémo : FR0013233012 / IVA Site web : www.inventivapharma.com Date Nombre de titres composant le capital en circulation Nombre total de droits de vote bruts(1) …

Statement of total voting rights and shares forming the company’s share capital as of April 11, 2025
Article R. 22-10-23 of the French Commercial Code Market: Euronext Paris ISIN code / Mnemo: FR0013233012 / IVA Web site: www.inventivapharma.com Date Number of shares outstanding Total voting rights, gross (1) Total voting rights, net (2) April 11, 2025 95 …

Combined General Meeting of May 22, 2025 - Availability of the preparatory documents
Daix (France), New York City (New York, United States), April 30, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of metabolic …

Assemblée Générale Mixte du 22 mai 2025 - Modalités de mise à disposition des documents préparatoires
Daix (France), New York City (New York, Etats-Unis), le 30 avril 2025 – Inventiva (Euronext Paris et NASDAQ : IVA) (« Inventiva » ou la « Société »), société biopharmaceutique spécialisée dans le développement clinique de petites molécules administrées par …

DBV Technologies Reports First Quarter 2025 Financial Results
Châtillon, France, April 30, 2025 DBV Technologies Reports First Quarter 2025 Financial Results DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT – CUSIP: 23306J309), a clinical-stage biopharmaceutical company, today …

DBV Technologies publie ses résultats financiers du 1er trimestre 2025
Châtillon, France, le 30 avril (22 :00 CEST) 2025 DBV Technologies publie ses résultats financiers du 1er trimestre 2025 DBV Technologies (Euronext : DBV - ISIN : FR0010417345 - Nasdaq Stock Market : DBVT-CUSIP :23306J309), société biopharmaceutique au …

TBBK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that The Bancorp, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
NEW YORK, April 30, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz …

APP INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that AppLovin Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
NEW YORK, April 30, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz …

MRVI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Maravai LifeSciences Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
NEW YORK, April 30, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz …

ZBIO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Zenas BioPharma, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
NEW YORK, April 30, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz …

ELF INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that e.l.f. Beauty, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
NEW YORK, April 30, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz …

RC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Ready Capital Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
NEW YORK, April 30, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz …

TMCI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Treace Medical Concepts, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
NEW YORK, April 30, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz …

Warp Launches “FreedomChain” to Help U.S. Brands Modernize the One Part of Their Supply Chain They Can Actually Control
Los Angeles, CA, April 30, 2025 (GLOBE NEWSWIRE) -- Warp, the tech-driven middle-mile logistics leader, has launched FreedomChain, a new program built to help brands and retailers optimize the one part of their supply chain they can still control: the …

OTC Markets Group Announces First Quarter 2025 Earnings Conference Call and Webcast
NEW YORK, April 30, 2025 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM) today announced it will report its financial results for the first quarter ended March 31, 2025, after the close of the U.S. capital markets on Wednesday, May 7, 2025. In …